Medindia

X

For the Treatment of Diabetic Neuropathy, a Drug That Has Disease-Modifying Potential Would Earn Similar Patient Share in the U.S. and Europe

Monday, February 22, 2010 Diabetes News J E 4
Advertisement
CNSBio's CNSB-001 Will Become Decision Resources' Clinical Gold Standard for Diabetic Neuropathy in 2013

For more information, contact:

Decision Resources

Christopher Comfort

781-296-2597

ccomfort@dresources.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Star Scientific Files Application with FDA for Ari...
S
NQF Conference Goes Beyond Reform to Advance Quali...